Prospective Clinical Study of Postoperative Individualized Adjuvant Chemotherapy for Patients with Non-Small-Cell Lung Cancer Based on mRNA Expression of the Molecular Markers <i>RRM</i>1, <i>TUBB</i>3, and <i>ERCC</i>1

<div>Survival analysis of patients’ gene expression detected or not in the gemcitabine treatment subgroup.</div>

Journal of Oncology

fig2

Figure 2

Figure 2: Prospective Clinical Study of Postoperative Individualized Adjuvant Chemotherapy for Patients with Non-Small-Cell Lung Cancer Based on mRNA Expression of the Molecular Markers <i>RRM</i>1, <i>TUBB</i>3, and <i>ERCC</i>1 

Figure 2 | Prospective Clinical Study of Postoperative Individualized Adjuvant Chemotherapy for Patients with Non-Small-Cell Lung Cancer Based on mRNA Expression of the Molecular Markers RRM1, TUBB3, and ERCC1 